Literature DB >> 24632292

Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.

Khoa D Nguyen1, Claudia Macaubas2, Phi Truong2, Nan Wang2, Tieying Hou2, Taejin Yoon2, Elizabeth D Mellins3.   

Abstract

Serum amyloid A (SAA) has recently been identified by our group as a mitogen for regulatory T cells (Treg). However, the molecular mechanism by which SAA induces Treg proliferation is unknown. Here we provide evidence that IL-1β and IL-6 are directly involved in the SAA-mediated proliferation of Treg. By engaging its several cognate receptors, SAA induces IL-1β and IL-6 secretion by monocytes and drives them toward an HLA-DR(hi) HVEM(lo) phenotype resembling immature dendritic cells, which have been implicated in tolerance generation. This monocyte-derived cytokine milieu is required for Treg expansion, as inhibition of IL-1β and IL-6 abrogate the ability of SAA to induce Treg proliferation. Furthermore, both IL-1β and IL-6 are required for ERK1/2 and AKT signaling in proliferating Treg. Collectively, these results point to a novel mechanism, by which SAA initiates a monocyte-dependent process that drives mitogenic signals in Treg.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-1β; IL-6; Monocytes; Regulatory T cells; Serum amyloid A

Mesh:

Substances:

Year:  2014        PMID: 24632292      PMCID: PMC4068397          DOI: 10.1016/j.molimm.2014.02.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  42 in total

Review 1.  Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.

Authors:  Adnan R Khan; Simon J Dovedi; Robert W Wilkinson; David I Pritchard
Journal:  Int Rev Immunol       Date:  2010-10       Impact factor: 5.311

Review 2.  IL-6: from its discovery to clinical applications.

Authors:  Tadamitsu Kishimoto
Journal:  Int Immunol       Date:  2010-04-21       Impact factor: 4.823

3.  IL-17-producing human peripheral regulatory T cells retain suppressive function.

Authors:  Gaëlle Beriou; Cristina M Costantino; Charles W Ashley; Li Yang; Vijay K Kuchroo; Clare Baecher-Allan; David A Hafler
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

4.  Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

Authors:  Rong L He; Jian Zhou; Crystal Z Hanson; Jia Chen; Ni Cheng; Richard D Ye
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

5.  Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A.

Authors:  Ni Cheng; Rong He; Jun Tian; Patrick P Ye; Richard D Ye
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  IL-1beta and IL-2 convert human Treg into T(H)17 cells.

Authors:  Florence Deknuydt; Gilles Bioley; Danila Valmori; Maha Ayyoub
Journal:  Clin Immunol       Date:  2009-02-11       Impact factor: 3.969

7.  Lysophosphatidylglycerol inhibits formyl peptide receptorlike-1-stimulated chemotactic migration and IL-1beta production from human phagocytes.

Authors:  Jae Woong Shim; Seong Ho Jo; Sang Doo Kim; Ha Young Lee; Jeanho Yun; Yoe Sik Bae
Journal:  Exp Mol Med       Date:  2009-08-31       Impact factor: 8.718

8.  Serum amyloid A: a novel biomarker for endometrial cancer.

Authors:  Emiliano Cocco; Stefania Bellone; Karim El-Sahwi; Marilisa Cargnelutti; Natalia Buza; Fattaneh A Tavassoli; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

9.  Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells.

Authors:  Ivo Marguti; Guilherme Lopes Yamamoto; Thaís Boccia da Costa; Luiz Vicente Rizzo; Luciana Vieira de Moraes
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

10.  Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.

Authors:  Carmela De Santo; Ramon Arscott; Sarah Booth; Ioannis Karydis; Margaret Jones; Ruth Asher; Mariolina Salio; Mark Middleton; Vincenzo Cerundolo
Journal:  Nat Immunol       Date:  2010-10-03       Impact factor: 25.606

View more
  10 in total

1.  Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Authors:  Yujuan Zhang; Saloni Gupta; Alexandra Ilstad-Minnihan; Sashi Ayyangar; Arielle D Hay; Virginia Pascual; Norman T Ilowite; Claudia Macaubas; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2018-06-19       Impact factor: 3.969

2.  The Kunitz chymotrypsin inhibitor from Erythrina velutina seeds displays activity against HeLa cells through arrest in cell cycle.

Authors:  Sheyla V Lucena; Fabíola P Rufino; Gioconda Emanuella Diniz de Dantas Moura; Luciana M A Rabêlo; Norberto K V Monteiro; André T Ferreira; Jonas E Aguilar Perales; Adriana F Uchôa; Giselle Z Justo; Caio F R de Oliveira; Ludovico Migliolo; Helena Bonciani Nader; Elizeu A Santos; Adeliana S Oliveira
Journal:  3 Biotech       Date:  2021-12-15       Impact factor: 2.406

3.  Tmem178 acts in a novel negative feedback loop targeting NFATc1 to regulate bone mass.

Authors:  Corinne E Decker; Zhengfeng Yang; Ryan Rimer; Kyung-Hyun Park-Min; Claudia Macaubas; Elizabeth D Mellins; Deborah V Novack; Roberta Faccio
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

4.  Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value.

Authors:  Yuhao Wang; Jie Yang; Qijie Zhang; Jiadong Xia; Zengjun Wang
Journal:  Transl Androl Urol       Date:  2019-12

5.  Genome-wide immunity studies in the rabbit: transcriptome variations in peripheral blood mononuclear cells after in vitro stimulation by LPS or PMA-Ionomycin.

Authors:  Vincent Jacquier; Jordi Estellé; Barbara Schmaltz-Panneau; Jérôme Lecardonnel; Marco Moroldo; Gaëtan Lemonnier; Jason Turner-Maier; Véronique Duranthon; Isabelle P Oswald; Thierry Gidenne; Claire Rogel-Gaillard
Journal:  BMC Genomics       Date:  2015-01-23       Impact factor: 3.969

Review 6.  Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Ghislain Opdenakker; Sofie Struyf; Jo Van Damme
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

7.  Immunological Changes in Monocyte Subsets and Their Association With Foxp3+ Regulatory T Cells in HIV-1-Infected Individuals With Syphilis: A Brief Research Report.

Authors:  Na Guo; Lifeng Liu; Xiaodong Yang; Ting Song; Guanxin Li; Li Li; Taiyi Jiang; Yanqing Gao; Tong Zhang; Bin Su; Hao Wu
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

8.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16

Review 9.  Exploring the Immunomodulatory Moonlighting Activities of Acute Phase Proteins for Tolerogenic Dendritic Cell Generation.

Authors:  Inmaculada Serrano; Ana Luque; Josep M Aran
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

10.  Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression.

Authors:  Ze Li; Yongwang Hou; Meng Zhao; Tianning Li; Yahui Liu; Jiao Chang; Li Ren
Journal:  J Ovarian Res       Date:  2020-06-09       Impact factor: 4.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.